SCSalih Cesur

Salih Cesur

*This is an algorithmically generated author record based on publicly available information.

Salih Cesur has a total of 303 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of vaccination rates with influenza vaccines in pregnant women and their attitudes towards these vaccines

    by Süheyla Aydoğmuş, Sümeyye Nur Ünsal Keser, Murat Gözüküçük, Salih Cesur, Yusuf Üstün

    Aims: Influenza infection is a significant cause of mortality and morbidity in pregnant women and newborns. Therefore, annual influenza vaccination is strongly recommended for pregnant women during any trimester during the influenza season. The aim of this study is to determine vaccination rates in pregnant individuals at risk for influenza infection and to determine the reasons for not being vaccinated in those who are not vaccinated. Methods: The study was conducted as a cross-sectional survey study on pregnant women aged 18-45 in the first, second and third trimesters who applied to the Health Sciences University Ankara Training and Research Hospital Gynecology and Obstetrics Clinic between November 2023 and April 2024. The researchers reviewed the relevant literature and prepared a survey consisting of 19 questions to be administered to the participants. Results: The mean age of the pregnant women included in the study was 25.66±5.2 (18-42) years, and the mean gestational age was 26.02±5.8 weeks (minimum 2 weeks - maximum 40 weeks).Of the participants, 334 (83.5%)did not believed that the flu vaccine was protective. 66 (16.5%) believe that it was protective.A doctor had recommended the flu vaccine to 229 (57.3%) of the participants. The concern that the flu vaccine might be harmful to the baby was the most important r eason for not getting flu vaccinated. Conclusion: Tables prepared for educational purposes make it possible to quickly and easily exchange information about vaccination between doctors and pregnant women. For this reason, influenza vaccination is an important part of pre-pregnancy, pregnancy and postpartum care. Gynecologists and obstetricians, family physicians; should recommend influenza vaccination to pregnant women and increase the vaccination rate of pregnant women. We believe that this approach will benefit the pregnant woman and the newborn.

  • Open Access

    Evaluation of Hepatitis B Vaccination Coverage and Serological Response in People Living with HIV

    by Sengül Üçer, Pınar Gürkaynak, Uğur Emre Gümüş, Melek Sena Altun, Şerife Altun Demircan, Esra Kaya Kılıç, Cigdem Ataman Hatipoglu, Gunay Tuncer Ertem, Salih Cesur, Sami Kınıklı

    Aim: People living with HIV (PLWH) face a heightened risk of acquiring hepatitis B virus (HBV) infection because these two viruses share common transmission pathways. HIV/HBV coinfection is associated with accelerated liver disease progression. Consequently, hepatitis B vaccination is a critical preventive measure for PLWH. This study was designed to assess the serological response to hepatitis B vaccination in PLWH.Material and Methods: PLWH followed at the Infectious Diseases and Clinical Microbiology Clinic who were seronegative for HBsAg, anti-HBs, and anti-HBc IgG were retrospectively identified. Anti-HBs levels measured 1 month to 1 year after the final vaccine dose were assessed. Criteria associated with low response (anti-HBs titer: <100 mIU/mL) and high response (≥100 mIU/mL) were also evaluated.Results: A total of 54 patients were included in the final analysis. The median age was 43 (range, 22–80) years and 25.9% of the patients were female. Forty-nine patients (90.7%) had anti-HBs levels ≥10 mIU/mL. Anti-HBs levels ≥100 mIU/mL were observed in 10 (28.6%) patients who had received at least one double-dose vaccination versus 3 (15.8%) patients who had not (p=0.341), and in 18 (51.4%) patients with undetectable HIV RNA versus 5 (26.3%) patients with detectable HIV RNA (p=0.091), without reaching statistical significance.Conclusion: Adherence to the hepatitis B vaccination schedule was found to be suboptimal. Identifying the underlying causes of poor vaccination adherence and implementing strategies to improve compliance are essential in PLWH.

  • Open Access

    Parvovirus B19 IgG-Defined Prior Exposure and Its Association with Anemia in Maintenance Hemodialysis Patients: A Cross-Sectional Comparative Study

    by Metin Özsoy, Salih Cesur, Mehmet Emin Demir, Feyza Bayrakdar Çağlayan, Murat Duranay, Uğur Hatipoğlu, Ramazan Öztürk, Simge Bardak Demir, Altan Aksoy

    Background: Parvovirus B19 (B19V) has a well-established tropism for erythroid progenitor cells and is a recognized cause of anemia in immunocompromised individuals. Patients with end-stage renal disease (ESRD) receiving maintenance hemodialysis are predisposed to anemia due to multiple mechanisms and are frequently exposed to healthcare settings, raising concern that prior B19V infection may contribute to anemia severity or resistance to erythropoiesis-stimulating agents (ESAs). However, data regarding the clinical relevance of B19V seroprevalence in hemodialysis patients remain limited. Methods: We conducted a single-center, observational cross-sectional study including 131 adult patients on maintenance hemodialysis and 50 healthy controls. Parvovirus B19 IgG serostatus was assessed by enzyme-linked immunosorbent assay (ELISA) and used exclusively as a marker of prior (past) exposure rather than active infection; our aim was to determine whether IgG-defined prior exposure leaves a measurable long-term imprint on erythropoiesis. None of the participants had clinical features suggestive of acute parvovirus infection or an unexplained aplastic episode at enrollment. Demographic data, comorbidities, dialysis characteristics, ESA use, and laboratory parameters (hemoglobin, hematocrit, mean corpuscular volume, inflammatory markers, and albumin) were collected. Between-group and within-cohort comparisons used non-parametric tests, and multivariable logistic and linear regression models were used to adjust for age, sex, and other relevant covariates. Results: Parvovirus B19 IgG seropositivity was common in both groups (64.9% of hemodialysis patients vs. 48% of controls; crude odds ratio [OR] 2.00, 95% confidence interval [CI] 1.03–3.88, p = 0.043). However, hemodialysis patients were substantially older and more often male; after adjustment for age and sex, dialysis status was no longer independently associated with seropositivity (adjusted OR 1.4, 95% CI 0.8–2.3, p = 0.20), and within the hemodialysis cohort seropositivity was not associated with age or sex. Hemodialysis patients exhibited significantly lower hemoglobin and hematocrit and higher inflammatory markers than controls, consistent with ESRD-related anemia. Within the hemodialysis cohort, B19 IgG-positive and IgG-negative patients did not differ in hemoglobin, hematocrit, mean corpuscular volume, C-reactive protein, albumin, or ESA use, and IgG serostatus remained unrelated to hemoglobin in a multivariable model adjusting for age, sex, inflammation, nutrition, dialysis vintage, and ESA use (adjusted β = −0.20 g/dL, 95% CI −0.68 to 0.28, p = 0.42). Past Parvovirus B19 exposure was therefore not associated with anemia severity or treatment requirements. Conclusions: In this cohort of stable maintenance hemodialysis patients, prior Parvovirus B19 exposure, as indicated by IgG seropositivity, was not associated with increased anemia severity, inflammation, or ESA use, and the higher crude seroprevalence in dialysis patients was attributable to their older age rather than to dialysis itself. Because IgG reflects past exposure only and IgM and viral DNA were not assessed, these findings apply strictly to past (IgG-defined) exposure and cannot address active or persistent B19V infection. They suggest that routine Parvovirus B19 IgG screening in asymptomatic hemodialysis patients is unlikely to be useful for anemia management, whereas active or persistent infection—detectable only by molecular testing—remains the more plausible contributor to unexplained or refractory anemia and merits study in selected patients.

  • Open Access

    Evaluation of pneumococcal and influenza vaccination rates and patients' attitudes towards these vaccines in hemodialysis patients

    by Hakkı Öztürk, Artuner Varlıbaş, Ayşegül Tuna, Salih Cesur, Mehmet Emin Demir, Aydın Çifci

    Aims: To assess pneumococcal and influenza vaccination rates among haemodialysis patients, and to evaluate their attitudes and beliefs regarding these vaccines. Methods: Between 20 January and 20 February 2024, a cross-sectional study was conducted across private dialysis centres in Ankara, Turkiye. A total of 200 patients undergoing haemodialysis for chronic kidney disease were included in the study. A face-to-face questionnaire administered by dialysis physician routine sessions captured demographic characteristics, vaccination status and reasons for vaccine hesitancy. Vaccination status was recorded as ever (yes/no); exact timing was not analysed. Descriptive statistics and comparative analyses were performed using IBM SPSS Statistics v22.0; two-sided p

  • Open Access

    Assessment of vaccination rates and attitudes toward pneumococcal, influenza, and COVID-19 vaccines among asthmatic patients and adults aged 65 years and older without asthma

    by Metin Özsoy, Gülden Bilgin, İsMail Arslan, Özge Altaş Baştuğ, Salih Cesur

    Aims: The aim of this study is to evaluate the vaccination rates and attitudes toward pneumococcal, influenza, and COVID-19 vaccines in asthmatic patients and individuals aged 65 years and older without asthma. Methods: The study was planned as a prospective observational study between September 15, 2023, and November 15, 2023. The study included a total of 220 outpatient patients, comprising asthma-diagnosed patients who visited the Pulmonology and Family Medicine outpatient clinics at Ankara Traning and Research Hospital, Health Sciences University, and 65-year-old adults without asthma. An informed consent form was completed by asthma patients and individuals aged 65 years and older without asthma who agreed to participate in the study. A questionnaire consisting of 15 questions was administered to these participants. A p-value of ≤0.05 was considered statistically significant. Results: Of the asthma patients who participated in the study, 75 (59.1%) were female and 35 (37.6%) were male. The mean age of the asthma patients was 48.93±11.03. Of the outpatient patients aged 65 years and older without asthma who participated in the study, 52 (40.9%) were female and 58 (62.4%) were male. The mean age was 72.08±4.97. Patients aged 65 years and older with asthma were excluded from the study. The average age of the 65-year-old and older outpatient patients without asthma who participated in the survey was statistically significantly higher than that of the asthma patient group. The influenza vaccination rate among asthma patients who participated in the survey was 30.3%, the pneumococcal vaccination rate was 27.4%, and the rate of COVID-19 vaccination was 83.6%. Among the 65-year-old and older outpatient patients without asthma who participated in the survey, the influenza vaccination rate was 69.7%, the pneumococcal vaccination rate was 72.6%, and the COVID-19 vaccination rate was 99%. There was a statistically significant difference between asthmatic patients and outpatient patients aged 65 years and older in terms of influenza and pneumococcal vaccination rates. Conclusion: Vaccination rates for influenza and pneumococcal vaccines were found to be very low among asthmatic patients and outpatients over the age of 65 without asthma, while COVID-19 vaccination rates were found to be high in both groups. We believe that providing adequate information to family physicians and other healthcare providers who examine asthma patients and individuals aged 65 and older about the benefits and potential side effects of influenza vaccines, as well as publishing news articles in the media highlighting the importance of vaccination for high-risk individuals, could help increase vaccination rates.


  • Open Access

    A case developing Candida auris related candidaemia following multiple drug-resistant Klebsiella pneumoniae meningitis after neurosurgical intervention

    by Oğuzhan Yıldız, Melike Ersoy, Seda Karataş, Metin Özsoy, Mehmet Emre Yıldırım, Mihriban Yücel, Serap Yağcı, Rukiye Berkem, Nilgün Karabıçak, Salih Cesur, et al.

    A 28-year-old man who underwent ventriculoperitoneal shunt (VPS) operation at another medical center due to epidural abscess and hydrocephalus was admitted due to deterioration of his general condition. WBC count was 9360/mm³, C-reactive protein (CRP) was 54 mg/L (normal range <5 mg/L) and glomerular filtration rate was 150 ml/min, while the results of other laboratory tests were nonspecific. He was receiving vancomycin and meropenem treatment. Urine cultures were taken during hospitalization and again 48 hours later and Candida auris (C. auris) growth of 105 cfu/ml was detected. On the 4th day of hospitalization, the patient was intubated due to decreased oxygen saturation, and while under meropenem and vancomycin treatment, carbapenem-resistant, gentamicin and ceftazidime-avibactam-susceptible and multidrug-resistant Klebsiella pneumoniae growth was detected in CSF culture. The patient's ventriculoperitoneal shunt was removed and hydrocephalus was followed with extra-ventricular drainage (EVD). Vancomycin treatment was discontinued and intrathecal (IT) gentamicin treatment was started. Due to the susceptibility of Klebsiella pneumoniae growth from deep tracheal aspirate to ceftazidime-avibactam, antibiotic treatment was changed to intravenous (IV) meropenem, IV ceftazidime-avibactam and IT gentamicin and treatment was continued for 10 days. No growth was detected in CSF culture obtained under treatment. On the 20th day of hospitalization due to deterioration of his clinical condition under treatment, tracheostomy was performed, he was intubated, blood and urine cultures were repeated and C. auris growth was detected in blood culture on the 27th day after hospitalization using VITEK MS MALDITOF (bioMérieux, France) microbiological identification system. Confirmation of the C. auris species and antifungal susceptibility testing was performed by the Mycology Reference Laboratory, Institute of Public Health and antibiotic treatment was stopped. According to the antifungal susceptibility test results, the patient was started on anidulafungin. In conclusion, nosocomial C. auris infection should be considered in patients with underlying predisposing factors such as long intensive care unit stays, broad-spectrum antibiotic use, surgical interventions, central venous catheter use, intubation and infection due to gram-negative bacteria.

  • Open Access

    An Infection Emergency Overlooked During the Pandemic Period Infective Endocarditis: Retrospective Chort Study

    by Esra Kaya Kiliç, Özlem Özteki̇n, Salih Cesur, Çiğdem Ataman Hati̇pOğlu, Şerife Altun Demi̇rCan, Fatma Şebnem Erdi̇nÇ, Günay Tuncer Ertem, Sami Kinikli

    Amaç: Enfektif endokarditler, enfeksiyon hastalıkları acillerinden olup, tedavi edilmediği takdirde mortal seyredebilir. Bu yazıda, kliniğimizde koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] pandemisi döneminde yatarak tedavi ettiğimiz enfektif endokardit olgularını retrospektif olarak irdelemeyi amaçladık. Gereç ve Yöntemler: Çalışmaya Sağlık Bilimleri Üniversitesi Ankara Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniğinde enfektif endokardit tanısıyla yatarak izlenen 16 hasta dâhil edildi. Hastaların tanısı modifiye Duke kriterlerine göre konuldu. Hastaların kan kültüründen izole edilen mikroorganizmalar konvansiyonel yöntemler, Matriks Destekli Lazer Desorpsiyonu/İyonizasyon Süresi-Kütle Spektrometresi (MALDI-TOF) ve VITEK-2 otomatize sistemleri ile tanımlandı, antibiyotik duyarlılıkları VITEK-2 otomatize sistemi ile belirlendi. Hastalarda kalp kapaklarındaki tutulum (vejetasyon, apse vb.) transtorasik ekokardiyografi (EKO) ve/veya transösofagial EKO (TEE) ile değerlendirildi. Bulgular: Çalışmaya dâhil edilen enfektif endokardit tanısı konulan 16 hastanın 9'u (%56) erkek, 7'si (%44) kadındı. Hastaların yaş aralığı 47-80 arasında, ortalama yaş 62,3 idi. Hastaların %81'i doğal kapak endokarditi, %19'u yapay kapak endokarditi idi. Fizik muayenede 13 hastada (%81,25) ateş mevcuttu. Üç hastada (%18,75) enfektif endokardit tanısı ile eş zamanlı septik emboli mevcuttu. Hastaların 13'ünde transtorasik EKO'da vejatasyon saptandı, 2 hastada EKO'da bulgu yok iken TEE'de vejetasyon görüldü, 1 hastada ise sadece TEE'de vejetasyon saptandı. Tüm hastaların 10'unda mitral, 4'ünde triküspit, 2'sinde aort kapak tutulumu mevcuttu. Hastaların kan kültüründen 19 mikroorganizma izole edildi. Beş hastada kan kültüründe birden fazla etken üremesi mevcuttu. Altı (%37,5) hastada operasyon (kapak replasmanı) uygulandı. Enfektif endokardit hastalarının 5'inde (%31,3) mortalite gelişti. Sonuç: Sonuç olarak, COVID-19 pandemisinde yüksek ateş yakınması ile başvuran veya nedeni belirlenemeyen ateş nedeniyle irdelenen olgularda enfektif endokarditin de ayırıcı tanıda akılda tutulması uygun bir yaklaşım olacaktır.

  • Hafif/Orta ve Ağır COVID-19 Pnömonili Hastalarda Akciğer Tutulumunun Yaygınlığı ve Kortikosteroid Tedavi Gereksinimi

    by Günay Tuncer Ertem, Selin Şenol, Oğuzhan Tokur, Elif Ergün, Fatma Şebnem Erdi̇nÇ, Çiğdem Ataman Hati̇pOğlu, Sami Kinikli, Salih Cesur, Şerife Altun Demi̇rCan, Esra Kaya Kiliç

  • Open Access

    Clinical and Radiological Features of Pyogenic and Brucellar Spondylodiscitis

    by Sengül Üçer, Salih Cesur, Özlem Öztekin, Şerife Altun Demircan, Cigdem Ataman Hatipoglu, Esra Kaya Kılıç, Gunay Tuncer Ertem, Şebnem Erdinç, Halime Araz, Saliha Kazcı, et al.

    Aim: Since spondylodiscitis continues to be seen with increasing incidence; thus, starting antibiotherapy targeted towards the etiological agent is crucial for reducing complications and mortality. This study aimed to determine the clinical and radiological characteristics of spondylodiscitis’ causative microorganisms. Material and Methods: Patients hospitalized in the Department of Infectious Diseases and Clinical Microbiology with a diagnosis of spondylodiscitis between 2015 and 2023 were retrospectively evaluated. Results: Low back pain was present in 97.5% of the total 40 patients as the most common symptom. Tissue biopsy culture results were obtained for 21 (52.5%) patients, with culture positivity observed in five (12.5%) patients. Consumption of raw milk/dairy products in the anamnesis and fever were found to be statistically significantly higher in patients with brucellosis (p < 0.001, p = 0.015), whereas neurological deficits were significantly higher in the pyogenic group (p = 0.007). No significant differences were observed between the pyogenic and brucella spondylodiscitis groups in terms of laboratory parameters (sedimentation rate, C-reactive protein, white blood cell count) and magnetic resonance imaging findings. Conclusion: Since no distinctive clinical and radiological parameters were identified for distinguishing between brucellar and pyogenic spondylodiscitis, serological tests for brucellosis should be investigated when considering the diagnosis, particularly in endemic regions. In cases of pyogenic spondylodiscitis, empirical antibiotic use prior to pathogen isolation may lead to delays in diagnosis and appropriate treatment, potentially resulting in complications such as neurological deficits. Therefore, interventional methods for tissue biopsy culture should be planned before antibiotherapy, especially in patients who do not immediately require antibiotherapy.

  • Ölümle Sonuçlanan Fulminan Meningokoksemi Olgusu

    by Batuhan Saydam, Hacer Ayteki̇n Börü, Rukiye Berkem, Serap Yağci, Emel Altintaş, Muhammedcan Şen, Elifsu Demi̇r, Salih Cesur, Nuriye Ünal Şahi̇n